These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10698035)

  • 1. Relationship between ovarian stimulation regimen and cytokine concentration in follicular fluid and their effect on fertilization and pregnancy outcome of patients undergoing ICSI program.
    Hammadeh ME; Braemert B; Baltes S; Georg T; Rosenbaum P; Schmidt W
    Am J Reprod Immunol; 2000 Jan; 43(1):12-20. PubMed ID: 10698035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ovarian stimulation regimen and interleukin level in pre-ovulatory follicular fluid and their effect on ICSI outcome.
    Hammadeh ME; Ertan AK; Georg MT; Rosenbaum P; Schmidt W
    Am J Reprod Immunol; 2002 Oct; 48(4):255-61. PubMed ID: 12516637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between cytokine concentration in follicular fluid of poor and high responder patients and their influence of ICSI-outcome.
    Hammadeh ME; Fischer-Hammadeh C; Georg T; Rosenbaum P; Schmidt W
    Am J Reprod Immunol; 2003 Aug; 50(2):131-6. PubMed ID: 12846676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor (FGF), intracellular adhesion molecule (sICAM-1) level in serum and follicular fluid of infertile women with polycystic ovarian syndrome, endometriosis and tubal damage, and their effect on ICSI outcome.
    Hammadeh ME; Fischer-Hammadeh C; Hoffmeister H; Huebner U; Georg T; Rosenbaum P; Schmidt W
    Am J Reprod Immunol; 2003 Aug; 50(2):124-30. PubMed ID: 12846675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.
    Asimakopoulos B; Schöpper B; Dawson A; Caglar GS; Vakalopoulos I; Al-Hasani S; Diedrich K; Nikolettos N
    J Endocrinol Invest; 2006 May; 29(5):RC5-8. PubMed ID: 16794358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist.
    Bahceci M; Ulug U; Turan E; Akman MA
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):93-8. PubMed ID: 16720073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles.
    Ferrari B; Pezzuto A; Barusi L; Coppola F
    Gynecol Endocrinol; 2006 Jun; 22(6):289-96. PubMed ID: 16785153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cytokine concentrations (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome.
    Hammadeh ME; Fischer-Hammadeh C; Hoffmeister H; Herrmann W; Rosenbaum P; Schmidt W
    Am J Reprod Immunol; 2004 Jan; 51(1):81-5. PubMed ID: 14725569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
    J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.
    Liu N; Ma Y; Li R; Jin H; Li M; Huang X; Feng HL; Qiao J
    Endocrine; 2012 Dec; 42(3):708-16. PubMed ID: 22678853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropins induce the release of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha from the human preovulatory follicle.
    Loret de Mola JR; Goldfarb JM; Hecht BR; Baumgardner GP; Babbo CJ; Friedlander MA
    Am J Reprod Immunol; 1998 Jun; 39(6):387-90. PubMed ID: 9645270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of follicular and serum VEGF and IGF-1 in ICSI patients: hMG vs rFSH.
    Bilge M; Ozdemirci S; Esinler D; Karahanoglu E; Esinler I; Aksu T
    Clin Exp Obstet Gynecol; 2015; 42(5):576-9. PubMed ID: 26524801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.
    Balasch J; Vidal E; Peñarrubia J; Casamitjana R; Carmona F; Creus M; Fábregues F; Vanrell JA
    Hum Reprod; 2001 Aug; 16(8):1636-43. PubMed ID: 11473955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program.
    Weisman Z; Dirnfeld M; Lissak A; Sorokin Y; Abramovici H
    Fertil Steril; 1989 Sep; 52(3):451-3. PubMed ID: 2506078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between sex hormone-binding globulin and pregnancy outcome in women undergoing controlled ovarian hyperstimulation for assisted reproduction.
    Lin KC; Sun MJ
    Endocr J; 2005 Aug; 52(4):407-12. PubMed ID: 16127207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.